Fusion Pharmaceuticals Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 106

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $2.19B

Fusion Pharmaceuticals General Information

Description

Manufacturer of radiopharmaceuticals focused on developing next-generation radiopharmaceuticals as precision medicines. The company specializes in targeted alpha therapeutics using proprietary linker technology to improve the safety and efficacy of radiopharmaceuticals, thereby enhancing the lives of cancer patients.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 270 Longwood Road South
  • Hamilton, Ontario L8P 0A6
  • Canada
+1 (289)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Parent Company
Vertical(s)
Corporate Office
  • 270 Longwood Road South
  • Hamilton, Ontario L8P 0A6
  • Canada
+1 (289)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Fusion Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 04-Jun-2024 $2.19B Completed Generating Revenue
6. PIPE 28-Feb-2023 Completed Generating Revenue
5. IPO 26-Jun-2020 Completed Generating Revenue
4. Early Stage VC (Series B) 25-Mar-2019 Completed Startup
3. Early Stage VC (Series A) 25-Sep-2017 Completed Startup
2. Seed Round 09-Jan-2016 Completed Startup
1. Spin-Off 22-Dec-2014 Completed Startup
To view Fusion Pharmaceuticals’s complete valuation and funding history, request access »

Fusion Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of radiopharmaceuticals focused on developing next-generation radiopharmaceuticals as precision medicines.
Drug Discovery
Hamilton, Canada
106 As of 2023

Boston, MA
 

Boston, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Fusion Pharmaceuticals Competitors (67)

One of Fusion Pharmaceuticals’s 67 competitors is Compass Therapeutics, a Formerly VC-backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Compass Therapeutics Formerly VC-backed Boston, MA
Ratio Therapeutics Venture Capital-Backed Boston, MA
Ariceum Venture Capital-Backed Berlin, Germany
NGM Biopharmaceuticals Private Equity-Backed South San Francisco, CA
Kymera Therapeutics Formerly VC-backed Watertown, MA
You’re viewing 5 of 67 competitors. Get the full list »

Fusion Pharmaceuticals Patents

Fusion Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024404739-A1 Psma-targeted radiopharmaceuticals for treatment of cancer Pending 18-Dec-2023
EP-4827938-A1 Psma-targeted radiopharmaceuticals for treatment of cancer Pending 18-Dec-2023
WO-2025129334-A1 Psma-targeted radiopharmaceuticals for treatment of cancer Inactive 18-Dec-2023
AU-2024298849-A1 Psma-targeted radiopharmaceuticals for treatment of cancer Pending 27-Jul-2023
EP-4750498-A1 Psma-targeted radiopharmaceuticals for treatment of cancer Pending 27-Jul-2023 A61K47/12
To view Fusion Pharmaceuticals’s complete patent history, request access »

Fusion Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Fusion Pharmaceuticals Former Investors (20)

Investor Name Investor Type Holding Investor Since Participating Rounds
Adams Street Partners PE/Buyout Minority
Avidity Partners Asset Manager Minority
CPP Investments Asset Manager Minority
Centre For Probe Development And Commercialization Corporation
FACIT Venture Capital Minority
You’re viewing 5 of 20 investors. Get the full list »

Fusion Pharmaceuticals Investments & Acquisitions (4)

Fusion Pharmaceuticals’s most recent deal was a Corporate Asset Purchase with RadioMedix (225Ac-PSMA I&T Program). The deal was made on 13-Feb-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
RadioMedix (225Ac-PSMA I&T Program) 13-Feb-2023 Corporate Asset Purchase Buildings and Property
Rainier Therapeutics (Vofatamab) 01-Sep-2022 Corporate Asset Purchase Buildings and Property
MediaPharma 31-Dec-2021 Merger/Acquisition Drug Discovery
Ipsen (IPN-1087) 01-Apr-2021 Corporate Asset Purchase Buildings and Property
To view Fusion Pharmaceuticals’s complete investments and acquisitions history, request access »

Fusion Pharmaceuticals ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Fusion Pharmaceuticals’s complete esg history, request access »

Fusion Pharmaceuticals FAQs

  • When was Fusion Pharmaceuticals founded?

    Fusion Pharmaceuticals was founded in 2014.

  • Where is Fusion Pharmaceuticals headquartered?

    Fusion Pharmaceuticals is headquartered in Hamilton, Canada.

  • What is the size of Fusion Pharmaceuticals?

    Fusion Pharmaceuticals has 106 total employees.

  • What industry is Fusion Pharmaceuticals in?

    Fusion Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Fusion Pharmaceuticals a private or public company?

    Fusion Pharmaceuticals is a Private company.

  • What is the current valuation of Fusion Pharmaceuticals?

    The current valuation of Fusion Pharmaceuticals is .

  • What is Fusion Pharmaceuticals’s current revenue?

    The current revenue for Fusion Pharmaceuticals is .

  • How much funding has Fusion Pharmaceuticals raised over time?

    Fusion Pharmaceuticals has raised $444M.

  • Who are Fusion Pharmaceuticals’s investors?

    Adams Street Partners, Avidity Partners, CPP Investments, Centre For Probe Development And Commercialization, and FACIT are 5 of 20 investors who have invested in Fusion Pharmaceuticals.

  • Who are Fusion Pharmaceuticals’s competitors?

    Compass Therapeutics, Ratio Therapeutics, Ariceum, NGM Biopharmaceuticals, and Kymera Therapeutics are some of the 67 competitors of Fusion Pharmaceuticals.

  • When was Fusion Pharmaceuticals acquired?

    Fusion Pharmaceuticals was acquired on 04-Jun-2024.

  • Who acquired Fusion Pharmaceuticals?

    Fusion Pharmaceuticals was acquired by AstraZeneca.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process